Weiming Penguin Invited to the 2023 Boyun Forum to Explore China's Pharmaceutical Industry from a Global Perspective
Article images may contain Chinese text.

Recently, the much-anticipated Boyun Forum took place in Shanghai as scheduled. With the theme “A Data-Driven Discussion of China's Pharmaceutical Industry from a Global Perspective,” the forum invited numerous well-known industry experts to discuss the future direction of China's pharmaceutical industry.
As a specialist in big data technologies and solutions for the pharmaceutical and healthcare industry, Weiming Penguin was invited to attend this Boyun Forum. It also set up a booth at the venue to showcase its innovative products and solutions for digital transformation in the pharmaceutical industry to attendees.

At the forum, Weiming Penguin's booth attracted considerable attention from attendees. We shared digital transformation solutions for the pharmaceutical industry with industry professionals and showcased our achievements and ideas in advancing the industry. We hoped to use this opportunity to share our industry experience with more professionals and explore further possibilities for collaboration.

As one of the representative companies in pharmaceutical digital transformation, Weiming Penguin has consistently worked to advance the industry's digital transformation and intelligent upgrading. Going forward, Weiming Penguin will continue to increase its investment in digital transformation and explore new scenarios for applying digital technologies.

We thank the Boyun Forum organizing committee for providing a platform to share experience, exchange ideas, and discuss the future direction of China's pharmaceutical industry with more partners. We believe that only through continuous communication and cooperation can our pharmaceutical industry become healthier and more prosperous! Going forward, Weiming Penguin will continue to strengthen communication and cooperation with the industry and work together to contribute more to the digital development of China's pharmaceutical industry.

